TRRI OTC
Alzex Neuropharma Inc.
1W: +0.0%
1M: +0.0%
3M: -66.7%
YTD: +100.0%
1Y: -99.4%
3Y: -99.7%
5Y: -99.6%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$88K
-294.4% ▼
Capital Expenditures
$0
+0.0% ▲
Free Cash Flow
-$88K
-294.4% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$801
+345.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2009 | FY2010 | FY2012 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$331K | $80K | -$38K | $22K | -$166K |
| Depreciation & Amort. | $72K | $71K | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $20K | -$79K | $67K | $23K | $75K |
| Other Non-Cash Items | -$51K | $138K | $26K | $0 | $3K |
| Operating Cash Flow | -$238K | $72K | $523 | $45K | -$88K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $89K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $195K | -$22K | $0 | -$45K | $0 |
| Financing Cash Flow | $195K | -$22K | $0 | -$45K | $89K |
| Net Change in Cash | -$43K | $50K | -$54K | $180 | $801 |
| Cash End of Period | $4K | $54K | $523 | $219 | $1K |
| Free Cash Flow | -$238K | $72K | $523 | $45K | -$88K |